Vericel · Health Care
VCEL
$46.64
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.VericelCorporation是一家公开交易的美国生物制药公司，2014年10月前名为AastromBio。AastromBio于1989年在密歇根州安娜堡成立。
Rate-sensitive利率敏感
Mid cap中盘
$2B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/ove筑底形态尚未确认（价格仍位于 10 日均线下方），且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$46.64
3.5% below 52-week high低于52周高点 3.5%
Market Cap市值
$2B
Normal volume正常成交量
P/E Ratio市盈率
142.9x
28.9x sector median
Beta贝塔
1.06
Moves about 1.1x the market波动幅度约为市场的 1.1 倍
RSI (14)RSI（14）
62
Elevated偏高
Next Earnings下次财报
2026-07-30 (11d)
Volatility Rank波动率分位
33th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
9.7% of float
Performance价格表现
| Period周期 | VCEL | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -0.8% | -1.5% | In line with the index与指数基本持平 |
| 1 Month近1月 | +19.2% | +0.6% | Beat the index by 18.6 points跑赢指数 18.6 个百分点 |
| 3 Months近3月 | +30.7% | +4.7% | Beat the index by 26.0 points跑赢指数 26.0 个百分点 |
| 6 Months近6月 | +24.7% | +7.8% | Beat the index by 16.9 points跑赢指数 16.9 个百分点 |
| Year to date年初至今 | +31.0% | +9.1% | Beat the index by 21.9 points跑赢指数 21.9 个百分点 |
| 1 Year近1年 | +28.6% | +19.4% | Beat the index by 9.2 points跑赢指数 9.2 个百分点 |
| 3 Years近3年 | +20.0% | +69.4% | Lagged the index by 49.4 points落后指数 49.4 个百分点 |
Technicals技术面
RSI (14)RSI（14）
62
Elevated偏高
vs 50-day相对50日均线
+18.9% vs 50-day avg
vs 200-day相对200日均线
+27.0% vs 200-day avg
Volatility rank波动率分位
33th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$45.20
Don't chase above不追高于
$46.64
Stop止损
$37.46
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
11
days until next report天后公布财报
2026-07-30
Estimates being raised — 1 analysts预期上调 — 1 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | VCEL | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 142.93x | 28.92 | 6% |
| P/B市净率 | 6.66x | 3.52 | 22% |
| P/S市销率 | 8.55x | 3.02 | 14% |
| Earnings yield盈利收益率 | 0.70% | 2.72 | 30% |
| FCF yield自由现金流收益率 | 1.05% | 3.94 | 18% |
| EV/EBITDA企业价值/EBITDA | 100.09x | 18.21 | 2% |
| P/FCF市值/自由现金流 | 95.40x | 22.42 | 5% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 17.3%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 39.8%
Free Cash Flow自由现金流
Margins利润率
4.7%Return on Equity股本回报率
3.4%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -4.43 |
| Current ratio流动比率 | 5.03 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $38.8M |
| Share count change (1y)股数变化（1年） | +2.0% |
Piotroski皮奥特罗斯基 7/8
Altman Z阿尔特曼Z: safe (10.7)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 12% of its sector on blended multiples综合估值倍数低于行业内 12% 的公司
Beta市场敏感度
1.06×
0.21×3×
Moves about 1.1× the market波动幅度约为市场的 1.1 倍
Financial Health财务健康
7/8
Altman阿尔特曼: safe
Strong financial health财务健康状况良好
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$3.2M net (0 buyers, 6 sellers)-$3.2M 净值（0 买家，6 卖家）
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 14, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 14, 2026
VCEL daily MACD crossed downVCEL 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $46.09.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$46.09。
Jul 7, 2026
VCEL made a new 52-week highVCEL 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $46.95.价格创出52周新高 — 全市场关注的动量/趋势极值。$46.95。
Jul 2, 2026
VCEL made a new 52-week highVCEL 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $46.98.价格创出52周新高 — 全市场关注的动量/趋势极值。$46.98。
Jun 25, 2026
VCEL made a new 52-week highVCEL 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $42.90.价格创出52周新高 — 全市场关注的动量/趋势极值。$42.90。
Jun 24, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 24, 2026
VCEL RSI reached overboughtVCEL RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $41.69.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$41.69。
Jun 23, 2026
Golden cross on VCELVCEL 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $40.39.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$40.39。
Jun 23, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Jun 22, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 22, 2026
VCEL RSI reached overboughtVCEL RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $40.47.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$40.47。
Showing last 15 of显示最近15条，共 260 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.18
Value价值
-0.9
Profitability盈利能力
+0.6
Quality质量
+0.3
Investment资本投入
-0.2
Low volatility低波动
-0.7
Low market beta低市场敏感度
-0.3
Earnings quality盈利质量
+0.5
Short interest空头兴趣
-0.8
Company Profile公司档案
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.VericelCorporation是一家公开交易的美国生物制药公司，2014年10月前名为AastromBio。AastromBio于1989年在密歇根州安娜堡成立。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Receivables stretch
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。